Acyclovir Tablet 200 mg (Acyclovir)
Acyclovir
Prescription medication
Baskan Biopharmaceutical Co., Ltd.
MFDS item code 199001899 · Notified 1990.09.10
This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children aged 2 years and older
This medication is used for the treatment and prevention of herpes simplex virus infections in the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating herpes zoster viral infections, particularly helping to alleviate acute phase pain. However, its efficacy against postherpetic neuralgia has not yet been firmly established. This medication is also utilized for the treatment of chickenpox in children over 2 years of age. Overall, it is effectively used for the treatment of various viral infections.
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, administration is recommended at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal absorption disorders, intravenous administration should be considered. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse neuropsychiatric reactions; take care to extend the dosing interval or reduce the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is recommended to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is recommended to reduce the dose to 800 mg of this drug per administration twice daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is recommended to reduce the dose to 800 mg of this drug per administration 3 times daily at approximately 8-hour intervals.
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) 2 years and older: Same as for adults. 2) Under 2 years: Administer 1/2 the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg of this drug per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.
This medication should not be used in patients who are allergic to this medication or its components. Patients with impaired kidney function may experience neurological side effects more readily, so care should be taken when using it. Patients with reduced liver function should be administered cautiously as there is a risk of further deterioration of liver function. Infants and children must use this medication with special caution and it should be used only to the minimum extent necessary. Elderly patients are likely to have impaired kidney function, which can lead to prolonged retention of the medication in the body, so careful adjustment of dosage and administration intervals is required. During the use of this medication, severe allergic reactions such as shock may occur infrequently; if symptoms such as hypotension, respiratory distress, or chest tightness occur, the medication should be stopped immediately and medical consultation sought. Skin rash, fever, blisters, hives, and other symptoms may occur, so if any of these symptoms arise, stop taking the medication and receive appropriate treatment. Alopecia, severe dermatitis, and severe inflammation of the skin and mucous membranes may also occur, requiring careful attention. Neuropsychiatric symptoms such as confusion, drowsiness, hallucinations, and seizures may manifest, especially in elderly patients or those with impaired kidney function. Kidney-related side effects such as worsening kidney function, hematuria, and proteinuria may occur, so it is necessary to regularly monitor kidney status. Blood abnormalities may manifest as anemia, changes in white blood cell count, and bleeding; any abnormal symptoms should be promptly reported. Hepatitis and jaundice may indicate liver dysfunction, which may necessitate liver function tests. Gastrointestinal side effects may include gastritis, nausea, vomiting, and diarrhea, and if symptoms are severe, medication should be discontinued. Fatigue, fever, muscle pain, and joint pain may occur, requiring careful observation of overall health. Arrhythmias and changes in blood pressure may occur, so if such symptoms arise, consulting with medical personnel is advised. Ureteral obstruction or urinary difficulties may rarely occur, and any abnormalities should be reported immediately. This medication is most effective when administered early in the onset of the disease, so it should be taken as soon as symptoms appear. Adequate hydration is crucial to prevent dehydration and protect kidney function during high-dose administration. Women who are pregnant or could become pregnant should carefully consider the risks to the fetus when using this medication, and during breastfeeding, it is recommended to stop nursing as the drug can pass into breast milk. It is advisable to avoid driving or operating hazardous machinery while taking this medication. When using this medication alongside other drugs, interactions may alter the effects or side effects, so patients should inform their healthcare provider of any other medications they are taking. In the case of overdose, serious neurological symptoms and kidney damage may occur, so if an overdose is suspected, immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius to safely preserve its effectiveness.
Light blue round tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Acyclovir
Prescription medication
Baskan Biopharmaceutical Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
Kyung dong Pharm Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Dongkwang Pharmaceutical Co., Ltd.

Acyclovir 400mg
Tablet · Prescription medication
Kyung dong Pharm Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Kyungdong Pharmaceutical Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Bebocon Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.